Bluebird Bio Stock Market Value
| BLUE Stock | USD 0.39 0.03 7.14% |
| Symbol | Bluebird |
Bluebird bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bluebird Bio. If investors know Bluebird will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bluebird Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.80) | Revenue Per Share 0.357 | Quarterly Revenue Growth 1.337 | Return On Assets (0.36) | Return On Equity (1.87) |
The market value of Bluebird bio is measured differently than its book value, which is the value of Bluebird that is recorded on the company's balance sheet. Investors also form their own opinion of Bluebird Bio's value that differs from its market value or its book value, called intrinsic value, which is Bluebird Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bluebird Bio's market value can be influenced by many factors that don't directly affect Bluebird Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bluebird Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bluebird Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bluebird Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Bluebird Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Bluebird Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Bluebird Bio.
| 11/12/2024 |
| 12/12/2024 |
If you would invest 0.00 in Bluebird Bio on November 12, 2024 and sell it all today you would earn a total of 0.00 from holding Bluebird bio or generate 0.0% return on investment in Bluebird Bio over 30 days. Bluebird Bio is related to or competes with Mersana Therapeutics, Zentalis Pharmaceuticals, Y MAbs, Travere Therapeutics, Madrigal Pharmaceuticals, Viking Therapeutics, and Sarepta Therapeutics. bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for ... More
Bluebird Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Bluebird Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Bluebird bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 10.2 | |||
| Information Ratio | 0.0092 | |||
| Maximum Drawdown | 146.1 | |||
| Value At Risk | (13.64) | |||
| Potential Upside | 7.89 |
Bluebird Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bluebird Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Bluebird Bio's standard deviation. In reality, there are many statistical measures that can use Bluebird Bio historical prices to predict the future Bluebird Bio's volatility.| Risk Adjusted Performance | 0.0221 | |||
| Jensen Alpha | (0.32) | |||
| Total Risk Alpha | (2.14) | |||
| Sortino Ratio | 0.0136 | |||
| Treynor Ratio | 0.0505 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Bluebird Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Bluebird bio Backtested Returns
At this point, Bluebird Bio is abnormally volatile. Bluebird bio secures Sharpe Ratio (or Efficiency) of 0.0106, which signifies that the company had a 0.0106% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Bluebird bio, which you can use to evaluate the volatility of the firm. Please confirm Bluebird Bio's Downside Deviation of 10.2, mean deviation of 6.29, and Risk Adjusted Performance of 0.0221 to double-check if the risk estimate we provide is consistent with the expected return of 0.16%. The firm shows a Beta (market volatility) of 5.01, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Bluebird Bio will likely underperform. Bluebird bio right now shows a risk of 15.43%. Please confirm Bluebird bio maximum drawdown and the relationship between the semi variance and day typical price , to decide if Bluebird bio will be following its price patterns.
Auto-correlation | -0.27 |
Weak reverse predictability
Bluebird bio has weak reverse predictability. Overlapping area represents the amount of predictability between Bluebird Bio time series from 12th of November 2024 to 27th of November 2024 and 27th of November 2024 to 12th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Bluebird bio price movement. The serial correlation of -0.27 indicates that nearly 27.0% of current Bluebird Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.27 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Bluebird bio lagged returns against current returns
Autocorrelation, which is Bluebird Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Bluebird Bio's stock expected returns. We can calculate the autocorrelation of Bluebird Bio returns to help us make a trade decision. For example, suppose you find that Bluebird Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Bluebird Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Bluebird Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Bluebird Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Bluebird Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Bluebird Bio Lagged Returns
When evaluating Bluebird Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Bluebird Bio stock have on its future price. Bluebird Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Bluebird Bio autocorrelation shows the relationship between Bluebird Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Bluebird bio.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Bluebird bio is a strong investment it is important to analyze Bluebird Bio's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Bluebird Bio's future performance. For an informed investment choice regarding Bluebird Stock, refer to the following important reports:Check out Bluebird Bio Correlation, Bluebird Bio Volatility and Bluebird Bio Alpha and Beta module to complement your research on Bluebird Bio. For information on how to trade Bluebird Stock refer to our How to Trade Bluebird Stock guide.You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.
Bluebird Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.